Former NBA veteran Tisdale dies after fight with cancer
Found on 15 May 2009 17:04 GMT
TULSA, Okla. (AP) - Former Oklahoma star and NBA player Wayman Tisdale has died at 44 after fighting cancer the past two years.
Sharing Cancer Info May Be Empowering
Found on 15 May 2009 13:03 GMT
FRIDAY, May 15 (HealthDay News) - Parents with family secrets may struggle to decide what to share with their children. But when it comes to cancer running in the family, a new study shows that those who choose to reveal the results of genetic tests are glad they did.
Biotechs Dangle Data for Cash at Cancer Drug Bazaar
Found on 15 May 2009 16:34 GMT
May 15 (Bloomberg) - Biotechnology companies struggling with funding shortages because of the global credit crisis will be scrambling for the attention of cash-rich drugmakers at the world?s largest annual meeting of cancer doctors.
Judge Rules Teen Must Get Cancer Meds
Found on 15 May 2009 16:36 GMT
A Minnesota judge has ruled a 13-year-old boy with a highly treatable form of cancer must get medical treatment.
Farrah's Heartwrenching Battle With Cancer
Found on 15 May 2009 15:00 GMT
On The Early Show, the host of "The Insider" discusses her interview of Farrah Fawcett's best friend, Alana Stewart, about documenting the star's ongoing battle with anal cancer.
Former Oklahoma star Tisdale, fighting cancer, dies
Found on 15 May 2009 14:56 GMT
Wayman Tisdale, a three-time All-American at Oklahoma who played 12 seasons in the NBA, died Friday after a two-year battle with cancer. He was 44.
Former player Tisdale dies at age 44 after bout with cancer
Found on 15 May 2009 15:47 GMT
Wayman Tisdale, a three-time All-American at Oklahoma who played 12 seasons in the NBA, died after a two-year battle with cancer. He was 44.
Colon Cancer Gene Test Can Predict Disease Return, Study Says
Found on 15 May 2009 12:46 GMT
May 15 (Bloomberg) - A gene test for colon cancer, developed by Genomic Health Inc., can help alert patients their cancer may recur after surgery, giving them a chance to protect themselves with chemotherapy, researchers said.
OSI Drops After Cancer Medicine Tarceva Disappoints
Found on 15 May 2009 14:48 GMT
May 15 (Bloomberg) - OSI Pharmaceuticals Inc. fell as much as 5.7 percent in Nasdaq trading after the company?s experimental lung cancer drug didn?t work as well as expected in a study.
OSI says Tarceva met goals in lung cancer trial
Found on 15 May 2009 14:02 GMT
OSI Pharmaceuticals Inc. and Roche's cancer pill Tarceva met its main goals in a clinical trial, as the drug stopped the spread of lung cancer longer than a placebo, OSI said late Thursday.
High-risk breast cancer predisposition genes.
Introduction Breast cancer is an important health issue. Worldwide, more than a million women are diagnosed with breast cancer every year. In the UK, breast cancer is the most commonly occurring cancer in women. Between 1 in 9 and 1 in 12 women in the UK will develop breast cancer during their
Screening for prostate cancer still a gray area: study findings raise questions about whether or not the PSA test saves lives.
Prostate cancer is the second-leading cause of cancer death in American men, killing more than 28,000 each year. While it's usually treatable if it's discovered soon enough, detecting the condition remains an inexact science. Two recent studies that evaluated the impact of prostate screening on
American Cancer Society Participates in California Regional White House Health Care Summit.
Byline: American Cancer Society OAKLAND, Calif., April 6 (AScribe Newswire) - The American Cancer Society, California Division's Chief Mission Delivery Officer, Dr. Carolyn Bruzdzinski, participated in a critical dialogue in support of health care reform today at the California Regional White
Singing about beating cancer
Singing about beating cancer - Hospital fetes its survivors By JOAN VERDON, STAFF WRITER Date: 06-08-2009, Monday Section: LOCAL Edtion: All Editions The 150 guests at the 11th annual Cancer Survivors' Day party at Hackensack University Medical Center on Sunday were a subdued bunch until the DJ
Research Reveals What Drives Lung Cancer's Spread.
Byline: Memorial Sloan-Kettering Cancer Center NEW YORK, July 2 (AScribe Newswire) - A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most
FIGHTBACK STARTS HERE; PROF HAILS TODAY AS THE MOST IMPORTANT: DAY FOR CANCER RESEARCH IN THE NORTH EAST.
Byline: ROBERT WEATHERALL EVERY cancer patient in the North East could be offered new drugs pioneered in Newcastle. In a groundbreaking move, the city was today unveiled as a centre for excellence in the fight against the disease, offering new hope for thousands. Experts from three of the country's
The Prostate Cancer Charity comments on new study using HIFU to treat men with the disease.
M2 PRESSWIRE-1 July 2009-The Prostate Cancer Charity: The Prostate Cancer Charity comments on new study using HIFU to treat men with the disease(C)1994-2009 M2 COMMUNICATIONS RDATE:01072009 The Prostate Cancer Charity comments on research published today (Wednesday 1 July), which suggests that
Managing the contralateral breast in a gene mutation carrier with breast cancer.
Introduction A major risk factor for breast cancer is a personal history of the disease, which is more important than female sex, age or family history. The risk for development of contralateral breast cancer is approximately 0.5-0.75% per year and the risk of dying from a contralateral lesion is
Calling All Runners: Join the Fight Against Cancer.
2009 Chicago Marathon Slots Still Available with the American Cancer Society Charity Runner Team REGISTER NOW CHICAGO, July 1 /PRNewswire/ - Just three months before 45,000 runners take to the streets of Chicago, the American Cancer Society Charity Runner Team is still offering entries to the sold
Johns Hopkins Medical Institutions, Department of Pathology publishes research in ovarian cancer therapy.
Research findings, 'Suppression of annexin A11 in ovarian cancer: implications in chemoresistance,' are discussed in a new report. According to a study from the United States, Ovarian cancer patients treated with cisplatin-based chemotherapy often develop acquired cisplatin resistance and,
